Způsob stanovení závažnosti a prognózy B-buněčné chronické lymfocytární leukémie

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Science. Official publication website can be found on muni.cz.
Title in English Method for magnitude and prognosis determination in B-cell chronic lymphocytic leukemia.
Authors

BRYJA Vítězslav KREJČÍ Pavel KAUCKÁ Markéta POSPÍŠILOVÁ Šárka MAYER Jiří KOZUBÍK Alois MALINOVÁ Karla KOTAŠKOVÁ Jana

Year of publication 2012
Type Patent
MU Faculty or unit

Faculty of Science

Publisher
State Czech Republic
Patent's number 303555
Description Method for magnitude and prognosis determination of chronic lymphocytic leukemia in biological samples of the pacients is based on the assesment of the expression of at least one protein belonging to the group of membrane receptors Vangl2, Celsr1 and Frizzled7, cytoplazmatic proteins Dvl2, Dvl3 and Prickle1, casein kinase 1 epsilon and casein kinase 2 alfa and secreted ligand Wnt5a orat least one of the genes encoding protein protein belonging to the group of membrane receptors Vangl2, Celsr1 and Frizzled7, cytoplazmatic proteins Dvl2, Dvl3 and Prickle1, casein kinase 1 epsilon and casein kinase 2 alfa and secreted ligand Wnt5a.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.